Detalles de la búsqueda
1.
Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer.
Cancer Control
; 30: 10732748231185047, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37339926
2.
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer.
J Clin Oncol
; 41(19): 3461-3468, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379691
3.
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.
J Clin Oncol
; 22(1): 23-30, 2004 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14665611
4.
Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer.
Cancer Epidemiol Biomarkers Prev
; 14(6): 1402-10, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15941948
5.
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.
J Clin Oncol
; 28(20): 3227-33, 2010 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20530282
6.
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.
J Clin Oncol
; 26(35): 5721-7, 2008 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19001325
7.
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.
Cancer
; 110(3): 670-7, 2007 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17559146
8.
Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.
J Clin Oncol
; 25(23): 3469-74, 2007 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-17687151
9.
Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.
J Clin Oncol
; 24(21): 3347-53, 2006 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16849748
10.
Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
J Clin Oncol
; 24(22): 3629-35, 2006 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16822845
11.
Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.
Cancer
; 101(10): 2170-6, 2004 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15470715
Resultados
1 -
11
de 11
1
Próxima >
>>